发明名称 |
METHOD OF TREATING CANCERS AND A PHARMACEUTICAL COMPOSITION THAT MAY BE USED IN PRACTICING SAID METHOD |
摘要 |
The method of treating a person having a cancer selected from carcinoma, sarcoma or hematopoietic cancer by administering (a) an effective amount of at least one anti-cancer drug selected from the group consisting of an epidermal growth factor receptor (EGFR) inhibitor, a vascular endothelial growth factor receptor (VEGFR) inhibitor and a Raf kinase inhibitor and (b) an effective amount of 5-(4-(6-(4-amino-3,5-dimethyl-phenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy)-benzyl)-thiazolidine-2,4-dione.dihydrochloride provided that said carcinoma is not lung cancer when an EGFR inhibitor is erlotinib. The invention also provides a pharmaceutical composition that may be used in practicing said method.
|
申请公布号 |
US2013183297(A1) |
申请公布日期 |
2013.07.18 |
申请号 |
US201313776997 |
申请日期 |
2013.02.26 |
申请人 |
DAIICHI SANKYO COMPANY, LIMITED;DAIICHI SANKYO COMPANY, LIMITED |
发明人 |
FUJIWARA KOSAKU;SHIMAZAKI NAOMI |
分类号 |
A61K31/427;A61K31/44;A61K31/5377;A61K39/395;A61K45/06 |
主分类号 |
A61K31/427 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|